Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 800 of 2228 entries
View as:

Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses of Dabigatran Etexilate on the Pharmacokinetic and Pharmacodynamic Parameters in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02171598 Org: User:
Start: 02/28/09 End: - Due: -

BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD

Phase: N/A Priority: Normal
NCT ID: NCT00846768 Org: User:
Start: 02/28/09 End: - Due: -

Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00876733 Org: User:
Start: 03/31/09 End: 12/31/13 Due: 12/31/14

A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT04750577 Org: User:
Start: 04/27/21 End: 12/27/22 Due: 12/27/23

Retrospective Follow-up of Synvisc® in Active Patients With Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02195492 Org: User:
Start: 04/30/02 End: - Due: -

This Study Tests BI 1467335 in Healthy Male Volunteers. The Study Tests How Different Doses of BI 1467335 Are Taken up and Handled by the Body

Phase: N/A Priority: Normal
NCT ID: NCT03382509 Org: User:
Start: 01/12/18 End: 04/19/18 Due: 04/19/19

Drug-drug Interaction of BI 201335 and Microgynon

Phase: N/A Priority: Normal
NCT ID: NCT01570244 Org: User:
Start: 04/30/12 End: 08/31/12 Due: 08/31/13

Filtered Trial for Amlodipine Non-responder

Phase: N/A Priority: Normal
NCT ID: NCT00558064 Org: User:
Start: 10/31/07 End: - Due: -

JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02848833 Org: User:
Start: 08/10/16 End: 04/17/20 Due: 04/17/21

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

Phase: N/A Priority: Normal
NCT ID: NCT07036523 Org: User:
Start: 09/26/25 End: 08/05/27 Due: 08/05/28

A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT06716190 Org: User:
Start: 12/18/24 End: 07/07/25 Due: 07/07/26

Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00106821 Org: User:
Start: 06/30/04 End: - Due: -

Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

Phase: N/A Priority: Normal
NCT ID: NCT02232594 Org: User:
Start: 01/31/00 End: - Due: -

Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole

Phase: N/A Priority: Normal
NCT ID: NCT00615914 Org: User:
Start: 02/29/04 End: - Due: -

Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)

Phase: N/A Priority: Normal
NCT ID: NCT02181985 Org: User:
Start: 05/31/00 End: - Due: -

A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Phase: N/A Priority: Normal
NCT ID: NCT03820726 Org: User:
Start: 04/16/19 End: 08/30/22 Due: 08/30/23

Safety, Tolerability, and Pharmacokinetics of BI 201335 NA in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02182297 Org: User:
Start: 04/30/08 End: - Due: -

GLORIA-AF Registry Program - Second and Third Phases

Phase: N/A Priority: Normal
NCT ID: NCT01468701 Org: User:
Start: 11/07/11 End: 01/10/20 Due: 01/10/21

The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage

Phase: N/A Priority: Normal
NCT ID: NCT02061748 Org: User:
Start: 10/28/14 End: 03/15/16 Due: 03/15/17

Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02999191 Org: User:
Start: 01/10/17 End: 04/10/17 Due: 04/10/18

A Study in Healthy Men to Test if Different Formulations of BI 764198 With or Without Food Influence the Amount of BI 764198 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT04656288 Org: User:
Start: 01/15/21 End: 03/15/21 Due: 03/15/22

Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02178306 Org: User:
Start: 09/30/00 End: - Due: -

Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02233907 Org: User:
Start: 10/31/99 End: - Due: -

Antistax® in Patients With Chronic Venous Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT02191280 Org: User:
Start: 04/30/98 End: - Due: -

Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02577315 Org: User:
Start: 09/30/15 End: 10/31/15 Due: 10/31/16